Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
25.12
+0.21 (0.84%)
At close: May 9, 2025, 4:00 PM
24.46
-0.66 (-2.63%)
After-hours: May 9, 2025, 4:07 PM EDT

Pacira BioSciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
283.61276.77153.3104.14585.5899.96
Upgrade
Short-Term Investments
210.02207.84125.28184.5170.83421.71
Upgrade
Cash & Short-Term Investments
493.63484.62278.58288.65656.41521.66
Upgrade
Cash Growth
51.47%73.96%-3.49%-56.03%25.83%78.68%
Upgrade
Accounts Receivable
104.75113.3105.5698.496.3253.05
Upgrade
Other Receivables
0.40.50.40.80.11.6
Upgrade
Receivables
105.15113.8105.9699.296.4254.65
Upgrade
Inventory
133.75125.28104.3596.0698.5564.65
Upgrade
Prepaid Expenses
27.4420.4320.414.3214.6710.67
Upgrade
Other Current Assets
-10.70.1--
Upgrade
Total Current Assets
759.96745.13509.99498.33866.05651.62
Upgrade
Property, Plant & Equipment
213.18216.39234.95254.39264.81211.18
Upgrade
Long-Term Investments
28.0329.4532.2660.1821.99109.48
Upgrade
Goodwill
21.52-163.24163.24145.1899.55
Upgrade
Other Intangible Assets
434.97425.97483.26540.55623.9796.52
Upgrade
Long-Term Deferred Tax Assets
129.01130.38144.49160.31153.36106.16
Upgrade
Other Long-Term Assets
-6.26.24.2--
Upgrade
Total Assets
1,5871,5541,5741,6812,0751,275
Upgrade
Accounts Payable
23.1719.1315.715.2210.5410.43
Upgrade
Accrued Expenses
80.0769.5255.7282.49118.668.78
Upgrade
Current Portion of Long-Term Debt
202.09201.788.6433.65374.7149.65
Upgrade
Current Portion of Leases
9.418.898.89.127.897.43
Upgrade
Current Income Taxes Payable
----0.430.11
Upgrade
Other Current Liabilities
-10.618.537.38.9516.93
Upgrade
Total Current Liabilities
314.73309.9297.38147.77521.12253.33
Upgrade
Long-Term Debt
381.29383.55513.8655.82674.53313.03
Upgrade
Long-Term Leases
43.6844.6554.8164.871.7371.03
Upgrade
Other Long-Term Liabilities
41.4337.0638.2737.7977.5717.44
Upgrade
Total Liabilities
788.13775.17704.26906.191,345654.83
Upgrade
Common Stock
0.050.050.050.050.050.04
Upgrade
Additional Paid-In Capital
1,0241,009976.63924.1942.09873.2
Upgrade
Retained Earnings
-201.54-206.36-106.8-148.75-211.9-253.88
Upgrade
Treasury Stock
-25.12-25.12----
Upgrade
Comprehensive Income & Other
1.350.340.25-0.380.170.32
Upgrade
Shareholders' Equity
798.54778.35870.13775.01730.41619.69
Upgrade
Total Liabilities & Equity
1,5871,5541,5741,6812,0751,275
Upgrade
Total Debt
636.46638.85586.04763.391,129541.13
Upgrade
Net Cash (Debt)
-142.83-154.24-307.46-474.74-472.44-19.47
Upgrade
Net Cash Per Share
-3.09-3.34-5.92-10.20-10.35-0.45
Upgrade
Filing Date Shares Outstanding
46.346.2846.545.9544.8543.86
Upgrade
Total Common Shares Outstanding
46.2846.2446.4845.9344.7343.64
Upgrade
Working Capital
445.23435.21412.61350.56344.93398.3
Upgrade
Book Value Per Share
17.2516.8318.7216.8716.3314.20
Upgrade
Tangible Book Value
342.05352.38223.6371.22-38.74423.62
Upgrade
Tangible Book Value Per Share
7.397.624.811.55-0.879.71
Upgrade
Machinery
187.03186.07141.5136.46133.3489.52
Upgrade
Construction In Progress
30.5328105.91103.2380.5671.09
Upgrade
Leasehold Improvements
86.6686.0361.8361.359.7454.43
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q